Incidence of oropharyngeal cancer on the rise

Source: News-Medical.netPublished: November 22, 2013  NCI scientists report that the incidence of oropharyngeal cancer significantly increased during the period 1983-2002 among people in countries that are economically developed. Oropharyngeal cancer occurs primarily in the middle part of the throat behind the mouth, including the base of the tongue, the side and back walls of the throat, and the tonsils. The results of this study, by Anil K. Chaturvedi, Ph.D., Division of Cancer Epidemiology and Genetics, NCI, and his colleagues, appeared online in the Journal of Clinical Oncology, Nov. 18, 2013. Recent studies from several countries have reported rising incidence of oropharyngeal cancers and subsequent studies have shown the human papilloma virus (HPV) as the potential cause. However, it has been unclear whether this increase in oropharyngeal cancer incidence represents a global phenomenon. Chaturvedi and his collaborators at Ohio State University and the International Agency for Research on Cancer evaluated incidence trends for oropharyngeal and oral cavity cancers. Their analysis was based on cancer registry data from more than 180,000 patients in 23 countries. They found that oropharyngeal cancer incidence increased overall among both women and men from 1983 to 2002, almost exclusively in economically developed countries. Among women, in all countries with significant increases in oropharyngeal cancer incidence, there was also an increase in incidence of both oral cancer and lung cancer, two cancers strongly associated with smoking. In contrast, among men, rising oropharyngeal cancer incidence was generally accompanied by decreases for oral cancer and lung cancer. These observations among [...]

2013-11-22T14:42:00-07:00November, 2013|Oral Cancer News|

Cancers attributable to human papillomavirus infection.

Source: PubMed.gov Although the human papillomavirus (HPV) vaccine was introduced primarily as a cervical cancer prevention vaccine, HPV has a causal role in several types of cancer. This article reviews the epidemiological evidence for the role of HPV in human cancer, and describes Australian trends in these cancers. HPV is a necessary cause of cervical cancer. The currently vaccine-preventable subtypes of HPV 16 and 18 are responsible for ~70% of cervical cancer. The introduction of an organised Pap smear program in Australia led to a steep decline in incidence over the past decades. HPV can be detected in ~40% and 70% of vulval and vaginal cancers respectively. Rates of these cancers have been stable over the past 20 years. The prevalence of HPV in penile cancer is ~50% and incidence has not recently changed. For anal cancer, ~85% of cases are HPV positive, and incidence has increased significantly in both men and women over the past 20 years. In the oral cavity, ~35% of oropharyngeal cancers and ~25% of other oral cavity cancers are HPV positive. The incidence of HPV-related oral cavity and oropharyngeal cancers is increasing, whereas incidence at HPV-unrelated sites is decreasing. Overall, 1154 HPV-related cancer cases were potentially preventable by vaccination. If HPV-related cancers at non-cervical sites are prevented by vaccination, then a similar number of cancer cases will be prevented as in the cervix. However, almost one-quarter of the potentially preventable cancer cases are in men, who are not included in the current national immunisation program.

2010-11-08T13:36:52-07:00November, 2010|Oral Cancer News|
Go to Top